5-methoxy 3-(1,2,3,6-tetrahydro-4-pyridinyl)1h indole has been researched along with scopolamine hydrobromide in 2 studies
Studies (5-methoxy 3-(1,2,3,6-tetrahydro-4-pyridinyl)1h indole) | Trials (5-methoxy 3-(1,2,3,6-tetrahydro-4-pyridinyl)1h indole) | Recent Studies (post-2010) (5-methoxy 3-(1,2,3,6-tetrahydro-4-pyridinyl)1h indole) | Studies (scopolamine hydrobromide) | Trials (scopolamine hydrobromide) | Recent Studies (post-2010) (scopolamine hydrobromide) |
---|---|---|---|---|---|
218 | 0 | 12 | 7,548 | 563 | 1,401 |
Protein | Taxonomy | 5-methoxy 3-(1,2,3,6-tetrahydro-4-pyridinyl)1h indole (IC50) | scopolamine hydrobromide (IC50) |
---|---|---|---|
Muscarinic acetylcholine receptor M4 | Homo sapiens (human) | 0.003 | |
Muscarinic acetylcholine receptor M1 | Rattus norvegicus (Norway rat) | 0.006 | |
Muscarinic acetylcholine receptor M3 | Rattus norvegicus (Norway rat) | 0.006 | |
Muscarinic acetylcholine receptor M4 | Rattus norvegicus (Norway rat) | 0.006 | |
Cytochrome P450 3A4 | Homo sapiens (human) | 0.0006 | |
Muscarinic acetylcholine receptor M5 | Rattus norvegicus (Norway rat) | 0.006 | |
Muscarinic acetylcholine receptor M2 | Rattus norvegicus (Norway rat) | 0.006 | |
Muscarinic acetylcholine receptor M1 | Homo sapiens (human) | 0.0026 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Noda, Y; Ochi, Y; Oka, M; Shimada, E | 1 |
Callaway, CW; Geyer, MA; Rempel, NL | 1 |
2 other study(ies) available for 5-methoxy 3-(1,2,3,6-tetrahydro-4-pyridinyl)1h indole and scopolamine hydrobromide
Article | Year |
---|---|
Involvement of central cholinergic mechanism in RU-24969-induced behavioral deficits.
Topics: Animals; Aziridines; Behavior, Animal; Choline; Indoles; Male; Mice; Mice, Inbred Strains; Motor Activity; Neuromuscular Blocking Agents; Neurons; Parasympathetic Nervous System; Parasympathomimetics; Scopolamine; Serotonin; Serotonin Antagonists | 1991 |
Serotonin1B receptor activation mimics behavioral effects of presynaptic serotonin release.
Topics: 3,4-Methylenedioxyamphetamine; Animals; Behavior, Animal; Caffeine; Designer Drugs; Dopamine Agents; Dose-Response Relationship, Drug; Fluoxetine; Indoles; Male; Motor Activity; N-Methyl-3,4-methylenedioxyamphetamine; Nicotine; Propranolol; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Scopolamine; Serotonin; Serotonin Receptor Agonists; Synapses | 1993 |